Machine Readiness
Stored receipt and evidence
20
65
0
0
0
Samples
No stored offer samples.
Samples
No stored action samples.
Samples
No stored product samples.
Document
User-agent: * Disallow: /search Disallow: /preview/ Disallow: /*[*]*$ Sitemap: https://www.cancernetwork.com/sitemap.xml Sitemap: https://www.cancernetwork.com/sitemap-news.xml Sitemap: https://www.cancernetwork.com/sitemap-videos.xml
Document
# CancerNetwork > CancerNetwork - Healthcare Publication - Base URL: https://www.cancernetwork.com - Generated: 2026-04-25T02:47:36.208Z - Content updates: multiple times daily ## Content Access for AI Agents This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML. **Supported content types:** - `text/markdown` — Clean Markdown with YAML frontmatter - `text/plain` — Plain text (same as Markdown) - `text/html` — Default HTML response **Example request:** ``` curl -H "Accept: text/markdown" https://www.cancernetwork.com/view/article-slug ``` **YAML frontmatter schema** (returned with every Markdown response): | Field | Type | Description | |-------|------|-------------| | `title` | string | Article headline | | `description` | string | Summary/excerpt (max 300 chars) | | `url` | string | Canonical article URL | | `canonical_url` | string | Canonical URL if different from `url` | | `published` | ISO 8601 | Original publication date | | `modified` | ISO 8601 | Last modification date | | `authors` | string[] | Author display names | | `content_type` | string | Content category (e.g., "News", "Clinical") | | `categories` | string[] | Taxonomy categories | | `tags` | string[] | SEO tags | | `image` | string | Featured image URL | | `publisher` | string | Publication/site name | **Discovery headers** (included on all responses): - `Link: <https://www.cancernetwork.com/llms.txt>; rel="llms"` — RFC 8288 link to this file - `X-Llms-Txt: https://www.cancernetwork.com/llms.txt` — Explicit discovery header ## Usage Policy - Robots policy: [https://www.cancernetwork.com/robots.txt](https://www.cancernetwork.com/robots.txt) - Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329) - Rate guidance: prefer RSS and sitemap feeds over crawling individual pages - Attribution: All content © MJH Life Sciences. Include source URLs when citing. ## Content Categories - [Around the Practice](https://www.cancernetwork.com/around-the-practice) - [Between the Lines](https://www.cancernetwork.com/between-the-lines) - [Breaking Barriers](https://www.cancernetwork.com/breaking-barriers) - [Clinical](https://www.cancernetwork.com/clinical) - [Clinical Consult](https://www.cancernetwork.com/clinical-consult) - [Conference](https://www.cancernetwork.com/conference) - [Face-Off](https://www.cancernetwork.com/face-off) - [From All Angles](https://www.cancernetwork.com/from-all-angles) - [Frontline Forum](https://www.cancernetwork.com/frontline-forum) - [Global Bulletin](https://www.cancernetwork.com/global-bulletin) - [Hero](https://www.cancernetwork.com/hero) - [Integrative Care](https://www.cancernetwork.com/integrative-care) - [Media](https://www.cancernetwork.com/media) - [Meeting of the Minds](https://www.cancernetwork.com/meeting-of-the-minds) - [Men's Health](https://www.cancernetwork.com/mens-health) - [News](https://www.cancernetwork.com/news) - [OncView](https://www.cancernetwork.com/k-cast) - [Podcasts](https://www.cancernetwork.com/podcasts) - [Publications](https://www.cancernetwork.com/journals) - [Quizzes](https://www.cancernetwork.com/resources/quizzes) - [Readout 360](https://www.cancernetwork.com/readout-360) - [Resources](https://www.cancernetwork.com/resources) - [Roles](https://www.cancernetwork.com/roles) - [The Bispecifics Network](https://www.cancernetwork.com/the-bispecific-network) - [Training Academy](https://www.cancernetwork.com/training-academy) - [Treatment Algorithms with the Oncology Brothers](https://www.cancernetwork.com/treatment-algorithms-with-the-oncology-brothers) - [Tumor Board Series](https://www.cancernetwork.com/tumor-board-series) - [Video Series](https://www.cancernetwork.com/video-series) - [Videos](https://www.cancernetwork.com/videos) - [Webinars](https://www.cancernetwork.com/webinars) - [Year in Review](https://www.cancernetwork.com/year-in-review) ## Featured Content - [This Week in Oncology: Real-World NSCLC Care and AACR 2026 Updates](https://www.cancernetwork.com/view/this-week-in-oncology-real-world-nsclc-care-and-aacr-2026-updates): Data presented at the 2026 AACR Annual Meeting highlighted promising therapeutic approaches in diseases like NSCLC and oral premalignant lesions. - [Taletrectinib Data Affirm Importance of Molecular Testing in NSCLC](https://www.cancernetwork.com/view/taletrectinib-data-affirm-importance-of-molecular-testing-in-nsclc): Penetration of molecular testing for non–small cell lung cancer in the US is not at 100%, according to Lyudmila Bazhenova, MD, FASCO. - [Examining Conversative Management in Low/Intermediate-Risk Prostate Cancer](https://www.cancernetwork.com/view/examining-conversative-management-in-low-intermediate-risk-prostate-cancer): Recently, conservative management has grown in popularity, especially among older patients and those with higher neighborhood-level socioeconomic stat... - [Discussing Proper Utilization of BCMA Bispecifics in Early Relapse Multiple Myeloma](https://www.cancernetwork.com/view/discussing-proper-utilization-of-bcma-bispecifics-in-early-relapse-multiple-myeloma): A panel of experts gathered to discuss the landscape of care in early-relapse multiple myeloma, new phase 3 data, and select patient cases. - [Future Directions and Unmet Needs in EGFR Mutated Metastatic Non-Small Cell Lung Cancer](https://www.cancernetwork.com/view/future-directions-and-unmet-needs-in-egfr-mutated-metastatic-non-small-cell-lung-cancer): In this closing segment, the panel reflects on ongoing unmet needs in the first line management of EGFR mutated metastatic non-small cell lung cancer. - [Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus–Positive DLBCL: A Rare Concomitant Association](https://www.cancernetwork.com/view/adult-t-cell-leukemia-lymphoma-and-epstein-barr-virus-positive-dlbcl-a-rare-concomitant-association) - [Redefining Long Term Success in EGFR Mutated Metastatic Non-Small Cell Lung Cancer](https://www.cancernetwork.com/view/redefining-long-term-success-in-egfr-mutated-metastatic-non-small-cell-lung-cancer): In this segment, the discussion returns to the theme of long term management in EGFR mutated metastatic non-small cell lung cancer. - [European Commission Approves Tovorafenib in BRAF+ Pediatric Low-Grade Glioma](https://www.cancernetwork.com/view/european-commission-approves-tovorafenib-in-braf-pediatric-low-grade-glioma): The conditional marketing authorization for tovorafenib in pediatric patients with low-grade glioma harboring a BRAF alteration is based on data from... - [Shifting Paradigms in the Surgical and Systemic Management of RCC](https://www.cancernetwork.com/view/shifting-paradigms-in-the-surgical-and-systemic-management-of-rcc): Patrick A. Kenney, MD, and David A. Braun, MD, PhD, discussed parameters they use to determine a patient’s eligibility for cytoreductive nephrectomy. - [The Synergy of Early Detection and KRAS Inhibition in Pancreatic Cancer](https://www.cancernetwork.com/view/the-synergy-of-early-detection-and-kras-inhibition-in-pancreatic-cancer): According to Diane Simeone, MD, parallel investments in early screening and novel therapeutics can improve survival rates in pancreatic cancer. ## Feeds and Indexes - [RSS Feed](https://www.cancernetwork.com/rss.xml): Latest articles in XML syndication format - [Sitemap](https://www.cancernetwork.com/sitemap.xml): Complete URL index for all published pages - [News Sitemap](https://www.cancernetwork.com/sitemap-news.xml): Recent articles optimized for news indexing - [Authors Directory](https://www.cancernetwork.com/authors): Browse all contributors and their published work
Document
Not stored for this site.